A detailed history of Trexquant Investment LP transactions in Novavax Inc stock. As of the latest transaction made, Trexquant Investment LP holds 150,085 shares of NVAX stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150,085
Previous 666,657 77.49%
Holding current value
$1.06 Million
Previous $8.42 Million 85.68%
% of portfolio
0.01%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$7.22 - $14.68 $3.73 Million - $7.58 Million
-516,572 Reduced 77.49%
150,085 $1.21 Million
Q3 2024

Nov 12, 2024

BUY
$10.71 - $17.11 $7.14 Million - $11.4 Million
666,657 New
666,657 $8.42 Million
Q2 2022

Aug 11, 2022

BUY
$36.28 - $75.29 $682,245 - $1.42 Million
18,805 New
18,805 $967,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $552M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.